Vesalius Biocapital Partners

Vesalius Biocapital Partners invests in companies active in human health through venture capital funds raised since 2007.

Business Model:

Revenue: $9.8M

Employees: 2-10

Rankings

Detailed Vesalius Biocapital Partners Information

Geographic Data

Vesalius Biocapital Partners headquarters map

Address: 1B rue Thomas Edison

City: Strassen

State: luxembourg

Zip: 1445

Country: LU

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$209M

Metrics

7,870,244Website Global Rank

420Website Monthly Traffic

Twitter Followers

Description

Vesalius Biocapital Partners invests in companies active in human health through venture capital funds raised since 2007. They have contributed to developing 20 companies since inception. With more than € 150 million under management in two funds. Vesalius Biocapital Partners plays the role of lead investor in the large majority of its financing rounds. Their companies are based in Europe allowing easy interaction with management. They invest in all stages of development and do not shy away from relatively early-stage projects with a sound proprietary technology and corresponding IP, unique team skills and a clear competitive edge based on solid data.

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
9/2021 Caresyntax Series C 130M
8/2019 Tonic App Venture Round 3.9M
10/2008 Apitope Series A 12.9M
11/2018 OMEICOS Therapeutics Series C 0
11/2009 Activaero Series A 15.8M
2/2011 Activaero Series A 0
10/2014 Ncardia Series A 5.1M
1/2013 FF Pharma Series A 5.3M
7/2019 DEARhealth Series A 6.8M
2/2010 Promethera Biosciences Series A 7.3M
4/2018 Sword Health Seed Round 0
7/2008 Genomic Vision Series B 6.3M
1/2017 Exact Imaging Series C 16.3M
2/2022 Memo Therapeutics Series B 0
10/2008 Trinean Venture Round 4.7M
7/2021 Topas Therapeutics Series B 0
3/2022 Scenic Biotech Series A 0
9/2011 Amakem Series A 25.2M
11/2014 Humedics Series C 7.8M
3/2017 OMEICOS Therapeutics Series B 0
10/2015 Ogeda Series B 17.9M
11/2012 Ogeda Private Equity Round 13M
1/2020 Mecuris Series B 0
6/2010 Complix Series A 6.2M
10/2013 TROD Medical Series B 6.6M
7/2019 Forendo Pharma Venture Round 0
6/2013 Complix Series B 15.6M
9/2015 Apitope Series B 0
3/2021 Rejuvenate Biomed Series A 0
10/2021 Rejuvenate Biomed Series B 0
8/2011 ProFibrix Series B 10.6M
4/2012 Trinean Venture Round 0
1/2015 Genkyotex Post-IPO Equity 0
5/2011 Genkyotex Series C 20.4M
7/2012 Genkyotex Series C 25.6M
11/2020 Catalym Series B 59.3M
10/2020 Topas Therapeutics Series B 0
11/2022 CatalYm Series C 0
10/2016 Promethera Biosciences Series C 10.9M
2/2020 OncoDNA Series B 0
11/2017 Ncardia Series B 12.4M
1/2019 Mecuris Series A 0
8/2019 Tonic App Series A 3.9M
2/2020 Sword Health Series A 0
9/2018 Forendo Pharma Venture Round 0
1/2021 Sword Health Series B 0
4/2015 OMEICOS Therapeutics Series A 0
3/2022 Scenic Biotech Series A 0
2/2022 Memo Therapeutics Series B 0
10/2021 Rejuvenate Biomed Series B 0
9/2021 Caresyntax Series C 0
7/2021 Topas Therapeutics Series B 0
3/2021 Rejuvenate Biomed Series A 0
1/2021 Sword Health Series B 0
11/2020 Catalym Series B 0
10/2020 Topas Therapeutics Series B 0
2/2020 Sword Health Series A 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research